Prostate Cancer

Incidence and Outcomes of Secondary Bladder Cancer Following Radiation Therapy for Prostate Cancer: A Systematic Review and Meta-analysis. January 27, 2025

Diuresis During 18F-Flotufolastat (rhPSMA-7.3) PET/CT Improves Recurrence Detection After Prostatectomy: A Prospective Phase II Trial. January 27, 2025

Clinical and Genomic Features of Androgen Indifferent Prostate Cancer. January 27, 2025

High-Intensity Focused Ultrasound Ablation for Primary or Salvage Prostate Cancer Therapy: Initial Outcomes in the Veteran Healthcare Setting. January 27, 2025

Extracellular Vesicles and Tunnelling Nanotubes as Mediators of Prostate Cancer Intercellular Communication. January 27, 2025

Meeting Cancer Detection Benchmarks in MRI/Ultrasound Fusion Biopsy for Prostate Cancer: Insights from a Retrospective Analysis of Experienced Urologists. January 27, 2025

An Updated Systematic Review and Network Meta-Analysis of First-Line Triplet vs. Doublet Therapies for Metastatic Hormone-Sensitive Prostate Cancer. January 27, 2025

Clarity Receives U.S. FDA Fast Track Designation for Cu-64 SAR-bisPSMA in Biochemical Recurrence of Prostate Cancer January 24, 2025

Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey. January 24, 2025

Next generation sequencing (NGS)-based molecular panel analysis for metastatic prostate cancer: how often can we detect druggable mutations? : NGS for metastatic adenocarcinoma of the prostate. January 24, 2025

Real-world effectiveness and cardiovascular safety of abiraterone versus enzalutamide amongst older patients diagnosed with metastatic castration-resistant prostate cancer. January 24, 2025

Prospective Validation of an Automated Hybrid Multidimensional MRI Tool for Prostate Cancer Detection Using Targeted Biopsy: Comparison with PI-RADS-based Assessment. January 24, 2025

An AI-Digital Pathology Algorithm Predicts Survival after Radical Prostatectomy from the PLCO Trial. January 24, 2025

Prostate-specific Membrane Antigen-radioguided Surgery in an EMBARK-like Cohort of Patients with Oligorecurrent Hormone-sensitive Prostate Cancer: Delay in Systemic Treatment. January 24, 2025

Clinical Validation of MyProstateScore 2.0 Testing Using First-Catch, Non-DRE Urine. January 23, 2025

Clinical significance of stratifying prostate cancer patients through specific circulating genes. January 23, 2025

Bridging the gap: Evaluating ChatGPT-generated, personalized, patient-centered prostate biopsy reports. January 23, 2025

Treatment algorithm following first-line therapy failure in metastatic prostate cancer. January 23, 2025

The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care. January 23, 2025

Initial clinical experience with [177Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial. January 23, 2025

Page 1 of 1454